首页 › 基金 › Spruce Street Capital LP › IKT
Spruce Street Capital LP 对 IKT 的持仓历史
INHIBIKASE THERAPEUTICS INC · 医疗保健
Spruce Street Capital LP 在 Q3 2026 的 13F 申报中披露持有 IKT(INHIBIKASE THERAPEUTICS INC)3,581,603 股,市值约 US$7.4M,约占其申报组合的 1.17%,在其申报持仓中市值排名第 22 位。 Spruce Street Capital LP 最近 4 个申报季度中有 4 个季度披露了 IKT 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Spruce Street Capital LP 对 IKT 的持仓演变
Spruce Street Capital LP 于 Q4 2025 首次披露 IKT 持仓:3,581,603 股(约 US$7.3M)。 该持仓在 Q3 2026 达到峰值 3,581,603 股,市值约 US$7.4M。 在 4 次申报中,Spruce Street Capital LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 3,581,603 股、市值约 US$7.4M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 3.58M | $7.34M | 新进 |
| Q1 2026 | 3.58M | $6.02M | 持有 |
| Q2 2026 | 3.58M | $7.27M | 持有 |
| Q3 2026 | 3.58M | $7.36M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IKT 与 13F 数据
IKT(INHIBIKASE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 IKT,申报仓位最大的包括:Sands Capital Alternatives, LLC (US$26.8M), Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IKT 的基金
- Sands Capital Alternatives, LLC 13.02M 股 · $26.82M · Q3 2026
- Soleus Capital Management, L.P. 10.88M 股 · $22.08M · Q2 2026
- Trails Edge Capital Partners, LP 9.05M 股 · $18.37M · Q2 2026
- Fairmount Funds Management LLC 8.62M 股 · $17.51M · Q2 2026
- ADAR1 Capital Management, LLC 7.39M 股 · $15.00M · Q2 2026
- Commodore Capital LP 5.40M 股 · $10.96M · Q2 2026
- Saturn V Capital Management LP 3.87M 股 · $7.85M · Q2 2026
- Kalehua Capital Management LLC 3.82M 股 · $7.85M · Q3 2026
- Squadron Capital Management LLC 3.00M 股 · $6.09M · Q2 2026
- Tyro Capital Management LLC 1.37M 股 · $2.81M · Q3 2026
- Kennondale Capital Management LLC 721.96K 股 · $1.48M · Q3 2026
- Stonepine Capital Management, LLC 647.28K 股 · $1.33M · Q3 2026
更多关于 Spruce Street Capital LP
常见问题
How long has Spruce Street Capital LP held IKT?
Spruce Street Capital LP has disclosed IKT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Spruce Street Capital LP's current position in IKT?
As of Q3 2026, Spruce Street Capital LP holds 3.58M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $7.36M, representing 1.17% of its reported portfolio and ranking #22.
Has Spruce Street Capital LP been buying or selling IKT?
In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in IKT. The position peaked in Q3 2026 at 3.58M shares.
Which other funds hold IKT?
Other major institutional holders of IKT include Sands Capital Alternatives, LLC, Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.